Although a similar meta-analysis of the CKD subgroups from GLP1- RA trials did not demonstrate consistent benefits [[72], the recently published FLOW trial specifically examined renal outcomes for subcutaneous semaglutide in individuals with type 2 diabetes and CKD [[73]
Insurance companies therefore either elect to exclude GLP-1 drugs from their drug formulary, or create barriers to accessing them
These medications arent magic, and they dont automatically teach nutrition skills
While buccal absorption is less efficient than sublingual, it is still better than sending the compound straight to the stomach
No significant differences were observed in subjects with weight loss surgeries, arthritis, or retinopathy
This guide explores the key principles of GLP-1 maintenance dosing, including how to adjust your dose after reaching your goals, what to expect when making dose changes, and why metrics beyond the scale often provide the most meaningful indicators of success